guanidinopropionic acid has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SY; Kang, TC; Kim, DW; Kim, JE; Kwon, OS; Ryu, HJ; Song, HK; Yeo, SI | 1 |
| Dienesch, C; Horn, M; Neubauer, S; Remkes, H; Strömer, H | 1 |
2 other study(ies) available for guanidinopropionic acid and Chronic Illness
| Article | Year |
|---|---|
Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.
Topics: Acute Disease; Animals; CA1 Region, Hippocampal; Chronic Disease; Creatine; Creatine Kinase; Disease Models, Animal; Epilepsy; Guanidines; Immunohistochemistry; Male; Membrane Transport Proteins; Propionates; Rats; Rats, Sprague-Dawley | 2010 |
Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction.
Topics: Adenosine Triphosphate; Animals; Blood Flow Velocity; Body Weight; Chronic Disease; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Guanidines; Heart; Heart Rate; Homeostasis; In Vitro Techniques; Ligation; Magnetic Resonance Spectroscopy; Myocardial Infarction; Organ Size; Phosphocreatine; Phosphorus Isotopes; Propionates; Rats; Rats, Wistar; Survival Rate; Ultrasonography; Ventricular Function, Left | 2001 |